From “slaynews.com”
A biotechnology firm funded by billionaire Bill Gates is advancing the development of its new mRNA “vaccine” spray.
The new sprayable “vaccine” is being developed by Ethris, a biotech startup based in Planegg, Germany.
In June 2024, Ethris received $5 million from the Bill & Melinda Gates Foundation to fund the development of the “vaccine.”
On Tuesday, Ethris received another $5 million from the Coalition for Epidemic Preparedness Innovations (CEPI).
The Gates Foundation co-founded CEPI in 2017.
The funding seeks to speed up the development of the mRNA spray to slow viral transmission and “end future disease outbreaks faster.”
However, experts warn that the “vaccines” pose health risks and are meant to overcome growing public objections to mRNA injections.
Ethris is working on a delivery method that allows for mRNA “vaccines” to be administered via a nasal strap rather than a shot.
According to CEPI, this latest round of funding will support the development of “spray-dried RNA vaccines that … are suitable for mucosal delivery.”
The nasal vaccines use spray-drying technology that is also used in asthma inhalers.
The mRNA spray “rapidly dries liquid with hot gas to form stable powders for respiratory delivery via the nose,” the Center for Infectious Disease Research and Policy reported.
According to CEPI, “nasal administration could help to achieve mucosal immunity which scientists believe is key for reducing virus transmission.”
The vaccine would remain stable at room temperature, CEPI added.
This would “eliminate the need for cold-chain logistics” used by existing mRNA injections.
CEPI claims this would make the sprayable “vaccines” making the products accessible to poorer countries
In a statement, Dr. Raafat Fahim, Ph.D., CEPI’s interim executive director of Manufacturing and Supply Chain, said:
“This technology may improve our ability to contain future epidemic or pandemic threats, compared to current RNA vaccines.”
Christian Plank, Ph.D., chief technology officer at Ethris, said:
“If successful, this approach has the potential to transform vaccine delivery and accessibility on a global scale.”
However, according to epidemiologist Nicolas Hulscher, the nasal sprays risk creating a public health crisis.
“Nasal administration of mRNA encoding for toxic antigens will still pose severe health risks,” Hulscher warns.
Hulscher explains that the nasal mucosa has a high concentration of blood vessels.
“Certain formulations of mRNA — especially those using lipid nanoparticles — may cross epithelial barriers and enter the bloodstream, leading to systemic, uncontrolled antigen production.”
In conventional Covid mRNA shots, lipid nanoparticles deliver mRNA to human cells.
However, researchers have found that lipid nanoparticles also deliver DNA contaminants into cells.
As Slay News has reported, DNA contamination causes cancers and other serious health risks.
This is not Ethris’s first foray into non-injectable mRNA vaccines, however.
In June 2024, the company received a grant from the Gates Foundation to fund the development of an inhaled mRNA “vaccine.”
The company claims inhaled mRNA has “the potential to address a broad spectrum of chronic respiratory diseases and emerging respiratory infections.”